What is Replimune Group's stock issuance proceeds?

Replimune Group (REPL) reported stock issuance proceeds of $791K in Q4 2025.

How has Replimune Group's stock issuance proceeds changed year-over-year?

Replimune Group's stock issuance proceeds decreased by 99.3% year-over-year, from $107.53M to $791K.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Replimune Group REPL Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Regeneron PharmaceuticalsREGN

$163.1M+169%

Inhibrx Biosciences, Inc.INBX

$471K—

ImmunomeIMNM

$229K+7.5%

CG OncologyCGON

$391.55M+57,312%

Erasca, Inc.ERAS

$258.75M+783,991%

IDEAYA Biosciences, Inc.IDYA

$1.19M+4.9%

Other financials

Income statement

See full

Operating income-$71.9M-8.9%

Net income-$70.9M-6.9%

EPS (diluted)-$0.77+2.5%

Balance sheet

See full

Cash & equivalents$124.7M-28.3%

Total debt$79.2M+0.5%

Total equity$210.5M-56.4%

Total assets$333.6M-44.7%

Cash flow

See full

Operating cash flow-$66.0M-30.1%

CapEx$135.0K-92.5%

Free cash flow-$66.1M-25.9%

Valuation

See full

Market cap$930.59M+30.2%

Enterprise value$885.15M+30.0%

Returns & leverage

See full

Return on equity-90.9%+362pp

Debt / equity0.4×+0.2×

Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Replimune Group's stock issuance proceeds?: Replimune Group (REPL) reported stock issuance proceeds of $791K in Q4 2025.
How has Replimune Group's stock issuance proceeds changed year-over-year?: Replimune Group's stock issuance proceeds decreased by 99.3% year-over-year, from $107.53M to $791K.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.